EU Becomes World’s Top Food Exporter
A report from the European Commission on the global farming market has revealed that the EU has beaten the US and become the world’s top exporter of agricultural and food products.
Huawei Signs Benchmark Deal with Euler Hermes
Euler Hermes, the global leader in trade credit insurance, and Huawei, a leading global ICT solutions provider, announced an agreement to cover the trade receivables for Huawei’s consumer device business in Europe.
Shire Rejects Takeover Offer from AbbVie
FTSE 100 pharmaceutical company Shire has rejected a takeover bid from US-based AbbVie. Shire’s shares price shot up by 13 percent in early London trading on 20th June following the announcement.
Lidl on course to become Europe’s Biggest Grocery Retailer
The company behind the Lidl supermarket chain is set to become western Europe’s biggest grocery retailer by 2018 as discounters become mainstream across the continent.
Medtronic to Buy Covidien
The world’s biggest medical devices maker (in terms of sales), Medtronic, will buy Ireland-based rival Covidien in a US $42.9 billion agreement that could increase concerns about the rush of US companies striking deals to cut their tax bills.
Europe’s Tech Sector Creates 30 $1 Billion-plus Businesses Since 2003
Europe has produced 30 technology companies worth more than $1 billion (£590m) since the millennium, according to research that explodes the myth that the region’s internet entrepreneurs lack vision and sell up too early;
Future Demand for Natural Gas Uncertain in Europe
A high price relative to coal and increasing use of renewable energy make future demand for natural gas especially uncertain in Europe.
Crossrail Project London Begins New Docklands Tunnel Drive
Crossrail is a £14.8 billion travel infrastructure project that is projected to improve rail links in the capital.
World Environment Day
World Environment Day is the opportunity for everyone to realise the responsibility of caring for the Earth and to become agents of change.
GlaxoSmithKline Strikes Deal with UK Firm Developing Cancer Treatments
GlaxoSmithKline (GSK) has struck a multimillion dollar deal with a British biotech firm to develop cutting-edge cancer treatments.
